Literature DB >> 2088188

Novel bacteriological assay for detection of potential antiviral agents.

T M Block1, R H Grafstrom.   

Abstract

A prototype assay for the initial screening of potential antiviral agents that uses bacterial growth on selective media is described. The human immunodeficiency virus (HIV) protease recognition sequence was inserted into the tetracycline resistance (Tet) protein encoded by plasmid pBR322 of Escherichia coli. Expression of both the HIV protease and the modified Tet protein prevented growth in the presence of tetracycline. However, inhibition of the HIV protease restored tetracycline resistance. Thus, potential HIV protease inhibitors can be identified by their ability to confer tetracycline resistance to this bacterial strain. The assay is simple, rapid, and inexpensive, and this concept can be applied to the search for inhibitors of other viral proteases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088188      PMCID: PMC172057          DOI: 10.1128/AAC.34.12.2337

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

2.  Two-codon insertion mutagenesis of plasmid genes by using single-stranded hexameric oligonucleotides.

Authors:  F Barany
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Intracistronic complementation of the tetracycline resistance membrane protein of Tn10.

Authors:  M S Curiale; L M McMurry; S B Levy
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

4.  Revised sequence of the tetracycline-resistance gene of pBR322.

Authors:  K W Peden
Journal:  Gene       Date:  1983 May-Jun       Impact factor: 3.688

5.  Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

Authors:  S Seelmeier; H Schmidt; V Turk; K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.

Authors:  C Debouck; J G Gorniak; J E Strickler; T D Meek; B W Metcalf; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli.

Authors:  L A Ivanoff; T Towatari; J Ray; B D Korant; S R Petteway
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Rational design of peptide-based HIV proteinase inhibitors.

Authors:  N A Roberts; J A Martin; D Kinchington; A V Broadhurst; J C Craig; I B Duncan; S A Galpin; B K Handa; J Kay; A Kröhn
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

9.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

Authors:  W G Farmerie; D D Loeb; N C Casavant; C A Hutchison; M H Edgell; R Swanstrom
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

View more
  5 in total

1.  HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.

Authors:  Taryn L O'Loughlin; Ichiro Matsumura
Journal:  Comb Chem High Throughput Screen       Date:  2006-05       Impact factor: 1.339

2.  Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.

Authors:  K Lindsten; T Uhlíková; J Konvalinka; M G Masucci; N P Dantuma
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

3.  Evolution of cyclic peptide protease inhibitors.

Authors:  Travis S Young; Douglas D Young; Insha Ahmad; John M Louis; Stephen J Benkovic; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

Review 4.  Fluorescent probes for proteolysis: tools for drug discovery.

Authors:  Jacques Neefjes; Nico P Dantuma
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

5.  A high capacity microbial screen for inhibitors of human rhinovirus protease 3C.

Authors:  J O McCall; S Kadam; L Katz
Journal:  Biotechnology (N Y)       Date:  1994-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.